He said the country requires long-term investments that do not hinge on quick profits but instead build a sustainable, ...

Celcuity Inc. soared on best-in-class Phase 3 breast cancer data. Click to see why I have a Buy rating on CELC due to data, ...

CytomX Therapeutics, Inc. is downgraded to Hold ahead of key CX-2051 Phase 1 expansion data in 1Q26. Learn more about CTMX ...

Shareholder‑Backed Investments Drive Commercial Readiness, Temple Partnership, and High‑Impact Economics for Customers TOMBALL, TX / ACCESS Newswire / December 23, 2025 / QS Energy, Inc. (OTC:QSEP) ...

Two private rail operators have publicly expressed interest in operating on the northern Shenandoah Valley’s dormant rail ...

No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...

Although there is no controlled research supporting the idea that patients need to be prepared to start evidenced-based treatments (EBTs) like cognitive processing therapy (CPT) or prolonged exposure ...

Fort McCoy’s Directorate of Public Works (DPW) and Xcel Energy continue to work together to finish the process of changing ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous (SC) formulation for the treatment of adult ...

The DfT needs a credible plan for managing capacity when HS2 services commence between Old Oak Common and Curzon Street ...

High-voltage transmission lines could cut through farmland and near communities around Lansing. Developers want input as they ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...